Pharvaris
Olivia Previte, MPH, is a Senior Clinical Trial Associate at Pharvaris since September 2023, previously serving as a Clinical Trial Associate. Prior experience includes roles as a Clinical Research Coordinator I & II at Dana-Farber Cancer Institute from June 2021 to September 2023, a Contact Tracer at Staffing Solutions Organization LLC, and an Intern with Handicap International - Humanity & Inclusion. Early career experiences involved research assistance at Boston University Center for Aging and Disability Education and Research, internships at the Boston Food Allergy Center, and tutoring with the Intergenerational Literacy Program. Olivia earned a Master’s degree in Epidemiology and Biostatistics from Boston University School of Public Health in May 2023 and a Bachelor of Science in Health Science from Boston University in 2021, following graduation from New Hartford Senior High School in 2017.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.